But studies link Abilify to compulsive behaviors, and European and Canadian regulatory organizations have essential drug companies to include new warnings to drug packaging about the enhanced risks.A examine within the Institute for Safe Medication Techniques (ISMP) uncovered that any drug that works by transforming the dopamine amounts can result